Evidence map›Paper›PMID 39094425›Full record

ArticleNuclear medicine and biology

[

Serge K Lyashchenko, Tuan Tran, Steffen Happel, Hijin Park, David Bauer, Kali Jones, Tullio V Esposito, NagaVaraKishore Pillarsetty, Jason S Lewis

Abstract read
In one paragraph

Article in Nuclear medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Serge K LyashchenkoRadiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: lyashchs@mskcc.org.
Tuan TranRadiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Steffen HappelTriskem International, Inc., USA.
Hijin ParkRadiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
David BauerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kali JonesDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Tullio V EspositoDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
NagaVaraKishore PillarsettyDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jason S LewisRadiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Leveraging Pb-203/212 for the Theranostic Imaging and Therapy of Prostate CancerR35CA232130 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LEWIS, JASON S. · 2019 to 2025
$8.2M
Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapyR01CA262675 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Nagavarakishore Pillarsetty · 2022 to 2026
$3.4M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA262675NCI NIH HHS R35 CA232130
6 · The paper itself

Abstract

introductionZirconium-89 (

methodsWe based our direct production of [

resultsA total of 18 batches, ranging from 6.9 to 20 GBq (186 to 541 mCi), were produced. The specific molar activity for [

conclusionIn this work, we report on a suitable application of TK400 Resin to remove iron during [

Indexed as

Heterocyclic Compounds, 1-RingIsotope LabelingRadioisotopesZirconiumAnimalsMicePositron-Emission TomographyRadiochemistryTissue Distribution1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidHeterocyclic Compounds, 1-RingRadioisotopesZirconiumZirconium-89[(89)Zr]zirconium chlorideDOTAPET imagingRadiolabeled peptides

Identifiers

PMID39094425
PMCPMC11438564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.